New Eczema Drug Gets FDA's Blessing

TUESDAY, March 28, 2017 — Adults plagued by eczema may have a new treatment option, with a new drug approved Tuesday by the U.S. Food and Drug Administration.
Dupixent (dupilumab) injections treat moderate-to-severe eczema in patients whose…
Source: Topamax